172
Views
4
CrossRef citations to date
0
Altmetric
Review

Molecular diagnosis of peanut allergy

, &
Pages 879-891 | Published online: 09 Jan 2014

References

  • Sicherer SH, Muñoz-Furlong A, Godbold JH, Sampson HA. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J. Allergy Clin. Immunol. 125(6), 1322–1326 (2010).
  • Venter C, Pereira B, Voigt K et al. Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life. Allergy 63(3), 354–359 (2008).
  • Sicherer SH, Muñoz-Furlong A, Burks AW, Sampson HA. Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. J. Allergy Clin. Immunol. 103(4), 559–562 (1999).
  • Sicherer SH, Muñoz-Furlong A, Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J. Allergy Clin. Immunol. 112(6), 1203–1207 (2003).
  • Osborne NJ, Koplin JJ, Martin PE et al.; HealthNuts Investigators. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J. Allergy Clin. Immunol. 127(3), 668–676.e1 (2011).
  • Prescott S, Allen KJ. Food allergy: riding the second wave of the allergy epidemic. Pediatr. Allergy Immunol. 22(2), 155–160 (2011).
  • Osterballe M, Hansen TK, Mortz CG, Høst A, Bindslev-Jensen C. The prevalence of food hypersensitivity in an unselected population of children and adults. Pediatr. Allergy Immunol. 16(7), 567–573 (2005).
  • Hourihane JO, Aiken R, Briggs R et al. The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry. J. Allergy Clin. Immunol. 119(5), 1197–1202 (2007).
  • Lack G. Clinical practice. Food allergy. N. Engl. J. Med. 359(12), 1252–1260 (2008).
  • Zijlstra WT, Flinterman AE, Soeters L et al. Parental anxiety before and after food challenges in children with suspected peanut and hazelnut allergy. Pediatr. Allergy Immunol. 21(2 Pt 2), e439–e445 (2010).
  • Cianferoni A, Spergel JM. Food allergy: review, classification and diagnosis. Allergol. Int. 58(4), 457–466 (2009).
  • Bernstein IL, Li JT, Bernstein DI et al.; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology. Allergy diagnostic testing: an updated practice parameter. Ann. Allergy Asthma Immunol. 100(3 Suppl. 3), S1–S148 (2008).
  • Boyce JA, Assa’ad A, Burks AW et al.; NIAID-Sponsored Expert Panel. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J. Allergy Clin. Immunol. 126(6 Suppl.), S1–S58 (2010).
  • Du Toit G, Santos A, Roberts G, Fox AT, Smith P, Lack G. The diagnosis of IgE-mediated food allergy in childhood. Pediatr. Allergy Immunol. 20(4), 309–319 (2009).
  • de Leon MP, Rolland JM, O’Hehir RE. The peanut allergy epidemic: allergen molecular characterisation and prospects for specific therapy. Expert Rev. Mol. Med. 9(1), 1–18 (2007).
  • Eigenmann PA, Oh JW, Beyer K. Diagnostic testing in the evaluation of food allergy. Pediatr. Clin. North Am. 58(2), 351–362 (2011).
  • Niederberger V, Stübner P, Spitzauer S et al. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J. Invest. Dermatol. 117(4), 848–851 (2001).
  • García BE, Lizaso MT. Cross-reactivity syndromes in food allergy. J. Investig. Allergol. Clin. Immunol. 21(3), 162–70 (2011).
  • Nicolaou N, Custovic A. Molecular diagnosis of peanut and legume allergy. Curr. Opin. Allergy Clin. Immunol. 11(3), 222–228 (2011).
  • Maleki SJ, Teuber SS, Cheng H et al. Computationally predicted IgE epitopes of walnut allergens contribute to cross-reactivity with peanuts. Allergy 66(12), 1522–1529 (2011).
  • Nicolaou N, Poorafshar M, Murray C et al. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J. Allergy Clin. Immunol. 125(1), 191–197.e1 (2010).
  • Wensing M, Knulst AC, Piersma S, O’Kane F, Knol EF, Koppelman SJ. Patients with anaphylaxis to pea can have peanut allergy caused by cross-reactive IgE to vicilin (Ara h 1). J. Allergy Clin. Immunol. 111(2), 420–424 (2003).
  • Turcanu V, Maleki SJ, Lack G. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J. Clin. Invest. 111(7), 1065–1072 (2003).
  • Turcanu V, Stephens AC, Chan SM, Rancé F, Lack G. IgE-mediated facilitated antigen presentation underlies higher immune responses in peanut allergy. Allergy 65(10), 1274–1281 (2010).
  • Turcanu V, Winterbotham M, Kelleher P, Lack G. Peanut-specific B and T cell responses are correlated in peanut-allergic but not in non-allergic individuals. Clin. Exp. Allergy 38(7), 1132–1139 (2008).
  • Turcanu V. Diagnostic biomarker discovery for peanut allergy. Int. Drug Discovery 6, 8–12 (2011).
  • Dearman RJ, Stone S, Caddick HT, Basketter DA, Kimber I. Evaluation of protein allergenic potential in mice: dose-response analyses. Clin. Exp. Allergy 33(11), 1586–1594 (2003).
  • Tay SS, Clark AT, Deighton J, King Y, Ewan PW. Patterns of immunoglobulin G responses to egg and peanut allergens are distinct: ovalbumin-specific immunoglobulin responses are ubiquitous, but peanut-specific immunoglobulin responses are up-regulated in peanut allergy. Clin. Exp. Allergy 37, 1512–1518 (2007).
  • Dreskin SC, Tripputi MT, Aubrey MT et al. Peanut-allergic subjects and their peanut-tolerant siblings have large differences in peanut-specific IgG that are independent of HLA class II. Clin. Immunol. 137(3), 366–373 (2010).
  • Ocmant A, Mulier S, Hanssens L et al. Basophil activation tests for the diagnosis of food allergy in children. Clin. Exp. Allergy 39(8), 1234–1245 (2009).
  • Peeters KA, Lamers RJ, Penninks AH et al. A search for biomarkers as diagnostic tools for food allergy: a pilot study in peanut-allergic patients. Int. Arch. Allergy Immunol. 155(1), 23–30 (2011).
  • Arias K, Waserman S, Jordana M. Management of food-induced anaphylaxis: unsolved challenges. Curr. Clin. Pharmacol. 4(2), 113–125 (2009).
  • Khodoun M, Strait R, Orekov T et al. Peanuts can contribute to anaphylactic shock by activating complement. J. Allergy Clin. Immunol. 123(2), 342–351 (2009).
  • Jönsson F, Mancardi DA, Kita Y et al. Mouse and human neutrophils induce anaphylaxis. J. Clin. Invest. 121(4), 1484–1496 (2011).
  • Mazuc E, Villoutreix BO, Malbec O et al. A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally. J. Allergy Clin. Immunol. 122(1), 188–194.e1 (2008).
  • Rancé F, Kanny G, Dutau G, Moneret-Vautrin DA. Food hypersensitivity in children: clinical aspects and distribution of allergens. Pediatr. Allergy Immunol. 10(1), 33–38 (1999).
  • Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS; Vaccine Safety Datalink Team. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J. Allergy Clin. Immunol. 113(3), 536–542 (2004).
  • de Silva IL, Mehr SS, Tey D, Tang ML. Paediatric anaphylaxis: a 5 year retrospective review. Allergy 63(8), 1071–1076 (2008).
  • Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 79(5), 683–688 (1987).
  • Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J. Allergy Clin. Immunol. 107(1), 191–193 (2001).
  • Hourihane JO, Roberts SA, Warner JO. Resolution of peanut allergy: case-control study. BMJ 316(7140), 1271–1275 (1998).
  • Skolnick HS, Conover-Walker MK, Koerner CB, Sampson HA, Burks W, Wood RA. The natural history of peanut allergy. J. Allergy Clin. Immunol. 107(2), 367–374 (2001).
  • Eigenmann PA. Mechanisms of food allergy. Pediatr. Allergy Immunol. 20(1), 5–11 (2009).
  • Ewan PW. Clinical study of peanut and nut allergy in 62 consecutive patients: new features and associations. BMJ 312(7038), 1074–1078 (1996).
  • Lack G, Fox D, Northstone K, Golding J; Avon Longitudinal Study of Parents and Children Study Team. Factors associated with the development of peanut allergy in childhood. N. Engl. J. Med. 348(11), 977–985 (2003).
  • Holloway JA, Warner JO, Vance GH, Diaper ND, Warner JA, Jones CA. Detection of house-dust-mite allergen in amniotic fluid and umbilical-cord blood. Lancet 356(9245), 1900–1902 (2000).
  • Szépfalusi Z, Loibichler C, Pichler J, Reisenberger K, Ebner C, Urbanek R. Direct evidence for transplacental allergen transfer. Pediatr. Res. 48(3), 404–407 (2000).
  • Loibichler C, Pichler J, Gerstmayr M et al. Materno-fetal passage of nutritive and inhalant allergens across placentas of term and pre-term deliveries perfused in vitro. Clin. Exp. Allergy 32(11), 1546–1551 (2002).
  • Edelbauer M, Loibichler C, Nentwich I, Gerstmayr M, Urbanek R, Szépfalusi Z. Maternally delivered nutritive allergens in cord blood and in placental tissue of term and preterm neonates. Clin. Exp. Allergy 34(2), 189–193 (2004).
  • Vance GH, Lewis SA, Grimshaw KE et al. Exposure of the fetus and infant to hens’ egg ovalbumin via the placenta and breast milk in relation to maternal intake of dietary egg. Clin. Exp. Allergy 35(10), 1318–1326 (2005).
  • Hattevig G, Sigurs N, Kjellman B. Effects of maternal dietary avoidance during lactation on allergy in children at 10 years of age. Acta Paediatr. 88(1), 7–12 (1999).
  • Frank L, Marian A, Visser M, Weinberg E, Potter PC. Exposure to peanuts in utero and in infancy and the development of sensitization to peanut allergens in young children. Pediatr. Allergy Immunol. 10(1), 27–32 (1999).
  • Strid J, Thomson M, Hourihane J, Kimber I, Strobel S. A novel model of sensitization and oral tolerance to peanut protein. Immunology 113(3), 293–303 (2004).
  • Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization. Clin. Exp. Allergy 35(6), 757–766 (2005).
  • Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur. J. Immunol. 34(8), 2100–2109 (2004).
  • Saloga J, Renz H, Larsen GL, Gelfand EW. Increased airways responsiveness in mice depends on local challenge with antigen. Am. J. Respir. Crit. Care Med. 149(1), 65–70 (1994).
  • Parvataneni S, Gonipeta B, Tempelman RJ, Gangur V. Development of an adjuvant-free cashew nut allergy mouse model. Int. Arch. Allergy Immunol. 149(4), 299–304 (2009).
  • Escudero C, Quirce S, Fernández-Nieto M, Miguel J, Cuesta J, Sastre J. Egg white proteins as inhalant allergens associated with baker’s asthma. Allergy 58(7), 616–620 (2003).
  • Chan SM, Turcanu V, Stephens AC, Fox AT, Grieve AP, Lack G. CLA T lymphocyte responses are associated with peanut allergy whilst a4b7 responses are associated with tolerance. Allergy 67, 336–342 (2012).
  • Du Toit G, Katz Y, Sasieni P et al. Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J. Allergy Clin. Immunol. 122(5), 984–991 (2008).
  • Hollams EM, Hales BJ, Bachert C et al. Th2-associated immunity to bacteria in teenagers and susceptibility to asthma. Eur. Respir. J. 36(3), 509–516 (2010).
  • Hollams EM, Hart PH, Holt BJ et al. Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur. Respir. J. 38(6), 1320–1327 (2011).
  • Holt PG, Rowe J, Kusel M et al. Toward improved prediction of risk for atopy and asthma among preschoolers: a prospective cohort study. J. Allergy Clin. Immunol. 125, 653–659, 659.e1–659.e7 (2012).
  • Wainstein BK, Studdert J, Ziegler M, Ziegler JB. Prediction of anaphylaxis during peanut food challenge: usefulness of the peanut skin prick test (SPT) and specific IgE level. Pediatr. Allergy Immunol. 21(4 Pt 1), 603–611 (2010).
  • Anagnostou K, Clark A, King Y, Islam S, Deighton J, Ewan P. Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin. Exp. Allergy 41(9), 1273–1281 (2011).
  • Blumchen K, Ulbricht H, Staden U et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J. Allergy Clin. Immunol. 126(1), 83–91.e1 (2010).
  • Kim EH, Bird JA, Kulis M et al. Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J. Allergy Clin. Immunol. 127(3), 640–646.e1 (2011).
  • Leung DY, Sampson HA, Yunginger JW et al.; Avon Longitudinal Study of Parents and Children Study Team. Effect of anti-IgE therapy in patients with peanut allergy. N. Engl. J. Med. 348(11), 986–993 (2003).
  • Jones SM, Pons L, Roberts JL et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J. Allergy Clin. Immunol. 124(2), 292–300, 300.e1 (2009).
  • Varshney P, Jones SM, Scurlock AM et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J. Allergy Clin. Immunol. 127(3), 654–660 (2011).
  • Sampson HA, Leung DY, Burks AW et al. A phase II, randomized, double-blind, parallel-group, placebo-controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J. Allergy Clin. Immunol. 127(5), 1309–1310.e1 (2011).
  • Patil SP, Wang J, Song Y et al. Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study. J. Allergy Clin. Immunol. 128(6), 1259–1265.e2 (2011).
  • Hamilton RG. Provocation tests with objective measures remain more diagnostic than surrogate immunoglobulin E antibody measures of sensitization. Clin. Exp. Allergy 41(8), 1048–1049 (2011).
  • Hamilton RG. Clinical laboratory assessment of immediate-type hypersensitivity. J. Allergy Clin. Immunol. 125(2 Suppl 2), S284–S296 (2010).
  • Roberts G, Lack G. Diagnosing peanut allergy with skin prick and specific IgE testing. J. Allergy Clin. Immunol. 115(6), 1291–1296 (2005).
  • Sampson HA. Clinical practice. Peanut allergy. N. Engl. J. Med. 346(17), 1294–1299 (2002).
  • Glaumann S, Nopp A, Johansson SG, Rudengren M, Borres MP, Nilsson C. Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children. Allergy 67(2), 242–247 (2012).
  • Wensing M, Penninks AH, Hefle SL, Koppelman SJ, Bruijnzeel-Koomen CA, Knulst AC. The distribution of individual threshold doses eliciting allergic reactions in a population with peanut allergy. J. Allergy Clin. Immunol. 110(6), 915–920 (2002).
  • Takhar P, Corrigan CJ, Smurthwaite L et al. Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J. Allergy Clin. Immunol. 119(1), 213–218 (2007).
  • Fox AT, Sasieni P, du Toit G, Syed H, Lack G. Household peanut consumption as a risk factor for the development of peanut allergy. J. Allergy Clin. Immunol. 123(2), 417–423 (2009).
  • Shamji MH, Wilcock LK, Wachholz PA et al. The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses. J. Immunol. Methods 317(1–2), 71–79 (2006).
  • Scadding GW, Shamji MH, Jacobson MR et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin. Exp. Allergy 40(4), 598–606 (2010).
  • Kulis M, Saba K, Kim EH et al. Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy. J. Allergy Clin. Immunol. 129, 1159–1162 (2012)
  • Valenta R, Twaroch T, Swoboda I. Component-resolved diagnosis to optimize allergen-specific immunotherapy in the Mediterranean area. J. Investig. Allergol. Clin. Immunol. 17(Suppl. 1), 36–40 (2007).
  • Hamilton RG, Saito H. IgE antibody concentration, specific activity, clonality, and affinity measures from future diagnostic confirmatory tests. J. Allergy Clin. Immunol. 122(2), 305–306 (2008).
  • Astier C, Morisset M, Roitel O et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J. Allergy Clin. Immunol. 118(1), 250–256 (2006).
  • Lucas JM. Microarrays: molecular allergology and nanotechnology for personalised medicine (I). Allergol. Immunopathol. (Madr.) 38(3), 153–161 (2010).
  • Sanz ML, Blázquez AB, Garcia BE. Microarray of allergenic component-based diagnosis in food allergy. Curr. Opin. Allergy Clin. Immunol. 11(3), 204–209 (2011).
  • Sastre J. Molecular diagnosis in allergy. Clin. Exp. Allergy 40(10), 1442–1460 (2010).
  • Vereda A, van Hage M, Ahlstedt S et al. Peanut allergy: Clinical and immunologic differences among patients from 3 different geographic regions. J. Allergy Clin. Immunol. 127(3), 603–607 (2011).
  • Ballabio C, Magni C, Restani P et al. IgE-mediated cross-reactivity among leguminous seed proteins in peanut allergic children. Plant Foods Hum. Nutr. 65(4), 396–402 (2010).
  • Restani P, Ballabio C, Corsini E et al. Identification of the basic subunit of Ara h 3 as the major allergen in a group of children allergic to peanuts. Ann. Allergy Asthma Immunol. 94(2), 262–266 (2005).
  • Fiocchi A, Nowak-Wegrzyn A. The fascinating world of molecular diagnosis in the management of food allergy: nondum matura est. Curr. Opin. Allergy Clin. Immunol. 11(3), 200–203 (2011).
  • Asarnoj A, Movérare R, Ostblom E et al. IgE to peanut allergen components: relation to peanut symptoms and pollen sensitization in 8-year-olds. Allergy 65(9), 1189–1195 (2010).
  • Codreanu F, Collignon O, Roitel O et al. A novel immunoassay using recombinant allergens simplifies peanut allergy diagnosis. Int. Arch. Allergy Immunol. 154(3), 216–226 (2011).
  • Nicolaou N, Murray C, Belgrave D, Poorafshar M, Simpson A, Custovic A. Quantification of specific IgE to whole peanut extract and peanut components in prediction of peanut allergy. J. Allergy Clin. Immunol. 127(3), 684–685 (2011).
  • Dang TD, Tang M, Choo S et al.; HealthNuts Study. Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. J. Allergy Clin. Immunol. 129(4), 1056–1063 (2012).
  • Borres MP, Ebisawa M, Eigenmann PA. Use of allergen components begins a new era in pediatric allergology. Pediatr. Allergy Immunol. 22(5), 454–461 (2011).
  • Guilloux L, Morisset M, Codreanu F, Parisot L, Moneret-Vautrin DA. Peanut allergy diagnosis in the context of grass pollen sensitization for 125 patients: roles of peanut and cross-reactive carbohydrate determinants specific IgE. Int. Arch. Allergy Immunol. 149(2), 91–97 (2009).
  • Vissers YM, Jansen AP, Ruinemans-Koerts J, Wichers HJ, Savelkoul HF. IgE component-resolved allergen profile and clinical symptoms in soy and peanut allergic patients. Allergy 66(8), 1125–1127 (2011).
  • Huss-Marp J, Darsow U, Brockow K et al. Can immunoglobulin E-measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen? Clin. Exp. Allergy 41(8), 1116–1124 (2011).
  • van Nieuwaal NH, Lasfar W, Meijer Y et al. Utility of peanut-specific IgE levels in predicting the outcome of double-blind, placebo-controlled food challenges. J. Allergy Clin. Immunol. 125(6), 1391–1392 (2010).
  • Flinterman AE, Pasmans SG, den Hartog Jager CF et al. T cell responses to major peanut allergens in children with and without peanut allergy. Clin. Exp. Allergy 40(4), 590–597 (2010).
  • Turcanu V. Could T cell component-resolved diagnosis differentiate between food sensitization and food allergy? Clin. Exp. Allergy 40(4), 531–533 (2010).
  • Valenta R, Linhart B, Swoboda I, Niederberger V. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens. Allergy 66(6), 775–783 (2011).
  • Kulis M, Pons L, Burks AW. In vivo and T cell cross-reactivity between walnut, cashew and peanut. Int. Arch. Allergy Immunol. 148(2), 109–117 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.